Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
CV Sciences, Inc. (CVSI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Second Quarter 2023 Financial Results"
06/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CV Sciences, Inc. 2023 EQUITY INCENTIVE PLAN Plan Adopted by the Board: April 11, 2023 Plan Approved by the Shareholders: June 1, 2023"
05/15/2023 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports First Quarter 2023 Financial Results"
03/29/2023 8-K Quarterly results
03/17/2023 4 Dowling Joseph D (CEO) has filed a Form 4 on CV Sciences, Inc.
Txns: Granted 2,500,000 options to buy @ $0.04, valued at $100k
03/17/2023 4 Grasser Joerg (CFO) has filed a Form 4 on CV Sciences, Inc.
Txns: Granted 1,250,000 options to buy @ $0.04, valued at $50k
03/02/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 2 of 51 Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 3 of 51 Case 2:15-cv-00481-RFB-VCF Document 105-3 Filed 06/01/22 Page 4 of 51",
"TO: ALL PERSONS WHO OWNED CANNAVEST CORP., NOW KNOWN AS CV SCIENCES, INC.",
"CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation"
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
11/07/2022 4 McCorkle William (Director) has filed a Form 4 on CV Sciences, Inc.
Txns: Granted 500,000 options to buy @ $0.04, valued at $20k
11/07/2022 3 McCorkle William (Director) has filed a Form 3 on CV Sciences, Inc.
10/25/2022 8-K Quarterly results
09/27/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"ORDER PRELIMINARILY APPROVING SETTLEMENT AND PROVIDING FOR NOTICE 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"NOTICE OF PROPOSED SETTLEMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ALDRICH LAW FIRM, LTD. JOHN P. ALDRICH 1601 S.",
"CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation"
08/15/2022 4 Corroon James Michael Jr. (Director) has filed a Form 4 on CV Sciences, Inc.
Txns: Granted 500,000 options to buy @ $0.0325, valued at $16.3k
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
07/29/2022 3 Corroon James Michael Jr. (Director) has filed a Form 3 on CV Sciences, Inc.
07/27/2022 8-K Resignation/termination of a director
06/06/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 8-K Quarterly results
04/15/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/04/2022 10-K Annual Report for the period ended December 31, 2021
04/01/2022 4 Grasser Joerg (CFO) has filed a Form 4 on CV Sciences, Inc.
Txns: Disposed/sold 750,000 options to buy @ $0.59, valued at $442.5k
Disposed/sold 750,000 options to buy @ $0.33, valued at $247.5k
Disposed/sold 250,000 options to buy @ $0.66, valued at $165k
04/01/2022 4 Dowling Joseph D (CEO) has filed a Form 4 on CV Sciences, Inc.
Txns: Disposed/sold 1,500,000 options to buy @ $0.33, valued at $495k
Disposed/sold 1,500,000 options to buy @ $0.59, valued at $885k
Disposed/sold 500,000 options to buy @ $0.66, valued at $330k
Disposed/sold 500,000 options to buy @ $0.4, valued at $200k
Disposed/sold 100,000 options to buy @ $0.38, valued at $38k
Disposed/sold 200,000 options to buy @ $0.73, valued at $146k
Disposed/sold 600,000 options to buy @ $0.38, valued at $228k
Disposed/sold 1,000,000 options to buy @ $0.368, valued at $368k
Disposed/sold 1,000,000 options to buy @ $0.365, valued at $365k
03/31/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/31/2022 8-K Quarterly results
Docs: "CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results"
03/28/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CV SCIENCES, INC. TO SECOND SUPPLEMENTAL INDENTURE TO INDENTURE DATED NOVEMBER 17, 2021",
"12544 High Bluff Drive"
03/28/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/21/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXECUTIVE EMPLOYMENT AGREEMENT"
12/01/2021 8-K/A Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy